Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD
ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.